Followers | 283 |
Posts | 1164 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Tuesday, July 20, 2021 11:30:10 AM
That may very well be the case!
To me, what you posted makes sense in light of the fact that Koos kicked into high gear to re-activate many of RGBP's Patents and in my mind WHY did he do this unless it was a buy out negotiation condition of a Big Pharma??
No Big Pharma is going to acquire any development stage Bio-Pharma with a portfolio of expired Patents. I already discussed this is a previous post.
Not only this to develop all those Patents is going to require some very serious money and logistics, the kind that only Big Pharmas have!
So this and in combo with him filing that 8K that protects against a Hostile Take Over during negotiations seems to fit a Buy Out-Merger Acquisition scenario.
My personal opinion.
Be well and prosper.
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM